Trials / Conditions / Complement Abnormality
Complement Abnormality
4 registered clinical trials studyying Complement Abnormality — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Complement Regulation to Undo Systemic Harm in Preeclampsia NCT04725812 | Cedars-Sinai Medical Center | Phase 2 |
| Completed | The Use of Eculizumab in HELLP Syndrome NCT04103489 | Johns Hopkins University | Phase 1 |
| Recruiting | Evaluation of a Renin Inhibitor, Aliskiren, Compared to Enalapril, in C3 Glomerulopathy NCT04183101 | Region Skane | Phase 2 |
| Unknown | The Role of Natural Killer, Complement and T-lymphocytes in COVID-19 Disease, a Prospective Monocentric Study NCT05258643 | Universitair Ziekenhuis Brussel | N/A |